TipRanks
Hofseth Biocare ASA (HOFBF)
OTHER OTC:HOFBF
US Market
HOFBF
Hofseth Biocare ASA
RESEARCH TOOLSreports

Hofseth Biocare ASA (HOFBF) Ratios

6 Followers

Hofseth Biocare ASA Ratios

HOFBF's free cash flow for Q1 2026 was kr-0.24. For the 2026 fiscal year, HOFBF's free cash flow was decreased by kr and operating cash flow was kr-0.69. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 ― 0.67 0.67 0.52 1.02
Quick Ratio
 ― 0.42 0.33 0.19 0.34
Cash Ratio
 ― 0.28 0.15 0.09 0.17
Solvency Ratio
 ― -0.20 -0.32 -0.20 -0.41
Operating Cash Flow Ratio
 ― -0.16 -0.06 0.01 -0.26
Short-Term Operating Cash Flow Coverage
 ― -0.33 -0.20 0.02 -83.64
Net Current Asset Value
kr ―kr -308.01Mkr -168.00Mkr -217.98Mkr -87.25M
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.76 0.50 0.72 0.25
Debt-to-Equity Ratio
 ― -4.02 2.85 6.71 0.70
Debt-to-Capital Ratio
 ― 1.33 0.74 0.87 0.41
Long-Term Debt-to-Capital Ratio
 ― 2.17 0.29 <0.01 <0.01
Financial Leverage Ratio
 ― -5.27 5.69 9.33 2.76
Debt Service Coverage Ratio
 ― -0.53 -1.07 -0.35 -9.36
Interest Coverage Ratio
 ― -4.94 -7.27 -13.59 -12.92
Debt to Market Cap
 ― 0.47 0.10 0.17 <0.01
Interest Debt Per Share
 ― 0.79 0.45 0.73 0.30
Net Debt to EBITDA
 ― -3.19 -2.14 -4.10 -0.77
Profitability Margins
Gross Profit Margin
―-12.76%34.13%22.67%23.67%
EBIT Margin
―-44.29%-39.68%-50.87%-105.80%
EBITDA Margin
―-28.80%-26.42%-32.19%-80.54%
Operating Profit Margin
―-44.29%-44.28%-52.61%-106.78%
Pretax Profit Margin
―-52.94%-48.68%-54.75%-114.07%
Net Profit Margin
―-53.01%-47.94%-54.74%-114.06%
Continuous Operations Profit Margin
―-53.01%-48.68%-54.75%-114.07%
Net Income Per EBT
―100.13%98.49%100.00%100.00%
EBT Per EBIT
―119.54%109.93%104.05%106.82%
Return on Assets (ROA)
―-34.21%-36.15%-27.35%-33.43%
Return on Equity (ROE)
―180.22%-205.52%-255.06%-92.38%
Return on Capital Employed (ROCE)
―-73.63%-65.91%-74.17%-53.86%
Return on Invested Capital (ROIC)
―-39.62%-49.09%-31.85%-51.00%
Return on Tangible Assets
―-34.49%-41.28%-31.86%-39.20%
Earnings Yield
―-24.86%-17.66%-10.31%-11.14%
Efficiency Ratios
Receivables Turnover
 ― 11.82 11.99 13.12 8.56
Payables Turnover
 ― 3.03 1.81 2.73 0.63
Inventory Turnover
 ― 4.80 3.03 1.83 0.79
Fixed Asset Turnover
 ― 1.73 1.87 1.18 0.71
Asset Turnover
 ― 0.65 0.75 0.50 0.29
Working Capital Turnover Ratio
 ― -3.75 -2.90 -3.32 10.52
Cash Conversion Cycle
 ― -13.39 -50.75 94.14 -73.40
Days of Sales Outstanding
 ― 30.87 30.43 27.81 42.64
Days of Inventory Outstanding
 ― 76.11 120.37 199.94 462.63
Days of Payables Outstanding
 ― 120.38 201.56 133.61 578.67
Operating Cycle
 ― 106.98 150.81 227.75 505.28
Cash Flow Ratios
Operating Cash Flow Per Share
 ― -0.09 -0.02 <0.01 -0.12
Free Cash Flow Per Share
 ― -0.16 -0.03 -0.03 -0.17
CapEx Per Share
 ― 0.06 <0.01 0.02 0.05
Free Cash Flow to Operating Cash Flow
 ― 1.66 1.42 -4.09 1.39
Dividend Paid and CapEx Coverage Ratio
 ― -1.52 -2.40 0.34 -2.54
Capital Expenditure Coverage Ratio
 ― -1.52 -2.40 0.34 -2.54
Operating Cash Flow Coverage Ratio
 ― -0.13 -0.06 <0.01 -0.43
Operating Cash Flow to Sales Ratio
 ― -0.15 -0.04 0.01 -0.38
Free Cash Flow Yield
―-11.75%-1.99%-1.09%-5.11%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -4.00 -5.67 -9.70 -8.97
Price-to-Sales (P/S) Ratio
 ― 2.13 2.71 5.31 10.24
Price-to-Book (P/B) Ratio
 ― -7.25 11.64 24.75 8.29
Price-to-Free Cash Flow (P/FCF) Ratio
 ― -8.51 -50.31 -91.59 -19.59
Price-to-Operating Cash Flow Ratio
 ― -14.11 -71.46 375.04 -27.30
Price-to-Earnings Growth (PEG) Ratio
 ― -0.40 -0.51 0.36 -1.57
Price-to-Fair Value
 ― -7.25 11.64 24.75 8.29
Enterprise Value Multiple
 ― -10.60 -12.41 -20.60 -13.47
Enterprise Value
 ― 776.35M 844.14M 1.29B 1.31B
EV to EBITDA
 ― -10.60 -12.41 -20.60 -13.47
EV to Sales
 ― 3.05 3.28 6.63 10.85
EV to Free Cash Flow
 ― -12.18 -60.77 -114.33 -20.77
EV to Operating Cash Flow
 ― -20.19 -86.31 468.12 -28.94
Tangible Book Value Per Share
 ― -0.19 0.05 -0.04 0.23
Shareholders’ Equity Per Share
 ― -0.18 0.15 0.11 0.40
Tax and Other Ratios
Effective Tax Rate
 ― >-0.01 0.00 0.00 >-0.01
Revenue Per Share
 ― 0.62 0.63 0.49 0.32
Net Income Per Share
 ― -0.33 -0.30 -0.27 -0.37
Tax Burden
 ― 1.00 0.98 1.00 1.00
Interest Burden
 ― 1.20 1.23 1.08 1.08
Research & Development to Revenue
 ― 0.00 0.06 0.06 0.11
SG&A to Revenue
 ― 0.34 0.32 0.11 0.15
Stock-Based Compensation to Revenue
 ― 0.00 0.00 0.00 0.00
Income Quality
 ― 0.29 0.08 -0.03 0.33
Currency in NOK